A review on bioanalytical method development and validation of anticancer drugs by using lc/ms/ms and its applications on routine analysis
Abstract
A protocol is used to detect and measure biomolecules and metabolites in human and animal tissues using bimolecular methods. The biosanalinity method is effective at determining the number of drugs and metabolites in a biological system. New methods, the validation of existing procedures, and the analysis of samples are one of the prominent tasks for bioanalysis. Above all, a compound can be measured using several methods and identified by different methods of analysis. Drugs may be tested by several extraction techniques, including liquid extraction, solid-phase extraction, and protein precipitation in complex plasma and biological samples. To determine how the environment, matrix, or procedures impact the matrix estimation to the time of the analysis, all steps in the process must be investigated. The more detailed study of drug products can be performed with higher-pressure analytical techniques, such as high- extraction (HPLC), liquid chromatography coupled with double-mass spectrometry (LCMS/MS), and ultra-performance Liquid chromatography (UPLC). Both of them have flaws and strengths. At present, HPLC and GC usually perform biolysis. The parameters are linearity, repeatability, accuracy, selectivity, and continuity. We are proposing the development and validation of bioanalytical systems to assist in the quality assurance of drugs.
References
2. D. Zimmer, Introduction to quantitative liquid chromatography-tandem mass spectrometry (LC-MS-MS), Chromatographia 57 (2003)325–332.
3. J. Schuhmacher, D. Zimmer, F. Tesche, V. Pickard, Matrix effects during an analysis of plasma samples by electrospray and atmospheric pressure chemical ionization mass spectrometry: practical approaches to their elimination, Rapid Commun. Mass Spectrom. 17 (2003)1950–1957.
4. Singh, A., Srinivasan, A.K., Chakrapani, L.N. and Kalaiselvi, P., 2019. LOX-1, the common therapeutic target in hypercholesterolemia: a new perspective of antiatherosclerotic action of aegeline. Oxidative medicine and cellular longevity, 2019.
5. T.M. Annesley, Ion suppression in mass spectrometry, Clin. Chem. 7 (2003) 1041–1047.
6. B.K. Matuszewski, M.L Constanzer, C.M. Chavez-Eng, Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS, Anal. Chem. 75 (2003) 3019– 3030.
7. Singh, A., Gowtham, S., Chakrapani, L.N., Ashokkumar, S., Kumar, S.K., Prema, V., Bhavani, R.D., Mohan, T. and Sathyamoorthy, Y.K., 2018. Aegeline vs Statin in the treatment of Hypercholesterolemia: A comprehensive study in rat model of liver steatosis. Functional Foods in Health and Disease, 8(1), pp.1-16.
8. A. V. Eeckhaut, K. Lanckmans, S. Sarre, I. Smolders, Y. Michotte, Validation of bioanalytical LC-MS/MS assays: Evaluation of matrix effects, J. Chromatogr. B, 877 (2009)2198–2207.
9. M. Ahnoff, A-C. Nyström, F. Schweikart, A. Ekdahl, Matrix effect explained by the unexpected formation of peptide in acidified plasma, Bioanalysis 7 (2015)295-306
10. M.W.J. van Hout, H.A.G. Niederländer, R.A. de Zeeuw, G.J. de Jong, Ion suppression in the determination of clenbuterol in urine by solid-phase extraction atmospheric pressure chemical ionization ion-trap mass spectrometry, Rap. Com. Mass Spec. 17 (2003) 245–250.
11. D. Remane, M.R. Meyer, F.T. Peters, D.K. Wissenbach, H.H. Maurer, Fast and simple procedure for liquid-liquid extraction of 136 analytes from different drug classes for the development of aliquidchromatographic tandem mass spectrometric quantification method in human blood plasma, Anal. Bioanal. Chem. 397(2010) 2303–2314
12. Rahul Singh,1 Ashok K. Shakya,2 Rajashri Naik,2 and NaeemShalan stability-indicating HPLC Determination of Gemcitabine in Pharmaceutical Formulations Hindawi Publishing Corporation International Journal of Analytical Chemistry Volume 2015, Article ID 862592, 12pages
13. Singh, A., Kumar, A. and Kalaiselvi, P., 2018. Aegeline, targets LOX1, the receptor for oxidized LDL to mitigate hypercholesterolemia: a new perspective in its anti-atherosclerotic action. Free Radical Biology and Medicine, 128, p.S41.
14. ShobhanaK.Menon∗,BhoomikaR.Mistry,KuldeepV.Joshi,PinkeshG.Sutariya,RavindraV. Patel Analytical detection and method development of anticancer drug Gemcitabine HCl using gold nanoparticles SpectrochimicaActa Part A: Molecular and BiomolecularSpectroscopy
15. Syed. Afrin, P. Prachet, Shaik.Munawar, Rama Rao. Nadendla Analytical Method Development and Validation of Gemcitabine in Tablets by HPLC by Different Analytical Techniques IOSR Journal Of Pharmacy And Biological Sciences (IOSR-JPBS) e-ISSN:2278-3008, p-ISSN:2319-7676. Volume 15, Issue 1 Ser. I (Jan –Feb 2020), PP24-29
16. Pawanpreet Kaur1* and Baljeet Singh analytical method development and validation of Gemcitabine: a review indo American journal of pharmaceutical sciences coden [USA]: IAJPBB ISSN: 2349-7750
17. Singh, A., 2022. Role of microbial metabolites in cardiovascular and human health. In Microbiome, Immunity, Digestive Health and Nutrition (pp. 137-148). Academic Press.
18. Konatham Teja Kumar Reddy, & M. Akiful Haque. (2022). Develop and validate a highly sensitive method for the estimation of Molnupiravir in rat plasma by high-performance liquid chromatography-tandem mass spectroscopy and its application to pharmacokinetic studies. Journal of Pharmaceutical Negative Results, 28–34. https://doi.org/10.47750/pnr.2022.13.S01.0
19. Konatham Teja Kumar Reddy, Penke Vijaya Babu, Rajinikanth Sagapola, & Peta Sudhakar. (2022). A REVIEW OF ARTIFICIAL INTELLIGENCE IN TREATMENT OF COVID-19. Journal of Pharmaceutical Negative Results, 254–264. https://doi.org/10.47750/pnr.2022.13.S01.31
20. Konatham Teja Kumar Reddy, Kumaraswamy Gandla, Penke Vijaya Babu, M Vinay Kumar Chakravarthy, Pavuluri Chandrasekhar, & Rajinikanth Sagapola. (2022). A CRITICAL REVIEW ON BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FEW ONCOLOGY DRUGS BY USING LC-MS-MS. Journal of Pharmaceutical Negative Results, 16–27. https://doi.org/10.47750/pnr.2022.13.S01.03
21. Reddy, K. T. K., & Haque, M. A. (2022). Bioanalytical method development and validation of atrasentan in human plasma using verapamil as internal standard by liquid chromatography coupled with tandem mass spectrometry. International Journal of Health Sciences, 6(S8), 625–638. https://doi.org/10.53730/ijhs.v6nS8.10470
22. Konatham Teja Kumar Reddy et.al High Performance Liquid Chromatography for The Simultaneous Estimation of Anti-Ulcer Drugs in Pharmaceutical Dosage Form, journal of Positive School Psychology, Vol. 6, No. 9, 4524-452
23. Reddy KTK, Haque MA. Development and Validation of a High Throughput Lc-Ms/MS Method for Quantitation of Ipilimumab in Human Plasma. International Journal of Pharmaceutical Quality Assurance. 2022;13(3):303-307
24. Teja Kumar Reddy Konatham, M. Anuradha (2020), a stability indicating method development and validation of Telmisartan and Nifedipine in pure form using RP-HPLC. International Journal of Pharmaceutical, Biological and Chemical Sciences, 9(3): 36-44
25. Teja Kumar Reddy Konatham, Satyanarayana Reddy K., Anuradha Manipogo,a Review on viruses that originated from china; Sars, mers and covid-19 World Journal of Pharmaceutical Research,Vol 9, Issue 5, 2020,2010-2015.
26. Teja Kumar Reddy Konatham et al,A Systematic Review on Method Development and Validation of Few Antiviral Drugs by Using RP-HPLC.Ijppr.Human, 2021; Vol. 21 (3): 651-661.
27. Konatham Teja Kumar Reddy and Kumaraswamy Gandla. Novel Vesicular Drug Delivery Systems Proniosomes. Pharm Res 2022, 6(3): 000272.
28. Roh, J., Hill, J.A., Singh, A.,Valero-Muñoz, M. and Sam, F., 2022. Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models. Circulation Research, 130(12), pp.1906-1925.
29. Asha Deepti et al / Stability Indicating Rp-Hplc Method For Assay Of Dexamethasone In Its Formulation, NEUROQUANTOLOGY, Stability Indicating Rp-Hplc Method For Assay Of Dexamethasone In Its Formulation| SEPTEMBER 2022 | VOLUME 20 | ISSUE 11 | PAGE 80-86| DOI: 10.14704/NQ.2022.20.11.NQ66009
30. Deepti, A., & Sahithi, A. (20Sensitiveitive bioanalytical method development and validation of afatinib in human plasma by LC-ESI-MS/MS. International Journal of Health Sciences, 6(S5), 1736– 1384. https://doi.org/10.53730/ijhs.v6nS5.9522
31. Kumar, K. P., Marathakam, A., Patnaik, S., Kumar, S., Sahithi, A., Priya, D. K. S., & Dogra, P. (2022). An insight of development and validation of bioanalytical method in the reference of anticancer drugs by using LC-MS/MS. International Journal of Health Sciences, 6(S3), 6349–6361. https://doi.org/10.53730/ijhs.v6nS3.7454
32. Sahithi et al., Stability indicating reverse-phase high-performance liquid chromatography method development and validation of imatinib, International Journal of Research and Analytical Reviews, Vol 7, Issue 3, 322-333, September 2020. DOI: 10.20959/wjpr20178-9069
33. Sahithi et al., Alapati Sahithi, B.Parijatha, D.Santhoshi Priya, Krishna Mohan Chinnala, Method Development and validation of Metformin by using RP-HPLC, World Journal of Pharmaceutical Research, 2277-7105, 6(8); August, 2017. DOI: 10.20959/wjpr20178-9069
34. K. Prashanthi*,E.Mounika,A. Sahithi, A. Chaitanya, C. Krishna MohanMethod Development and Validation for Determination of Dihydroergotamine in Dihydroergotamine Mesylate Nasal Spray Bidose by RP-HPLC, Journal of Xidian University (Scopus), 1001-2004, 16(4) Apr 22. Doi.org/10.37896/jxu16.4/042 ISSN No:1001-2400
35. 30.separations7030047 Cayman chemicals product information Ruxolitinib item number11609
36. Anjana Vaghela, Ashok Patel, Ajay Patel, Amit Vyas, NileshPatelSample Preparation In Bioanalysis: A review international journal of scientific & technology research volume 5, issue 05, May 2016 ISSN2277-8616
37. Wells DA. Fundamental strategies for bioanalytical sample preparation. High throughput bioanalytical sample preparation methods and automation strategies. Amsterdam: Elsevier; 2002. p. 41
38. Xu X. Book Using mass spectrometry for drug metabolism studies. In: Korfmacher W, editor. Chapter 7: Fast Metabolite Screening in a Discovery Setting. 2nd ed. CRC Press. 2010
39. Churchwell MI, Twaddle NC, Meeker LR, Doerge DR. Improving LCMS sensitivity through increases in chromatographic performance: Comparison of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J Chromatogr B AnalytTechnol Biomed Life Sci 2005;825:134-43.
40. sample preparation for bioanalysis 2012 evaluation group co and R @2011 water corporation
41. john Ayrton, ph.d., GlaxoSmithKline quantitative drug analysis and pharmacokinetics make synergistic partnership water the science of what's possible
42. Wenkui Li, Wenying Jian, and Yunlin Fu Protein Precipitation, Liquid-Liquid Extraction, and Solid‐Phase Extraction Basic Sample Preparation Techniques in LC‐MS Bioanalysis
43. Sarika Khasnis. Large Molecule Bioanalysis Outsourcing opportunities & Challenges. Pharma Focus Asia Magazine
44. Shiv Chandra Singh, A., Yu, A., Chang, B., Li, H., Rosenzweig, A. and Roh, J.D., 2021. Exercise Training Attenuates Activin Type II Receptor Signaling in the Aged Heart. Circulation, 144(Suppl_1), pp.A14259-A14259.
45. Bulletin 910 Guide to Solid Phase Extraction.hptt://www.supelco@sial.com:/©1998 Sigam- Aldrich Co.Page No.-3 [collected2011.10.10]
46. P. Wal, B. Kumar, Dr.A. Bhandari, A.k. Rai,AnkitWal. Bioanalytical Method Development- Determination of Drug in Biological Fluids. Journal of Pharmaceutical Science and technology vol.2 (10)210,333-347
47. P.LaxmanKole, G. Venkatesh, J. Kotechacand R. Sheshalad. Recent advances are βsample preparation techniques for effective bioanalytical methods. Biomedical Chromatography. 2011;25
48. K.Möller. Molecularly Imprinted Solid-Phase Extraction and Liquid Chromatography/Mass Spectrometry for Biological Samples Doctoral Thesis, Department of Analytical Chemistry Stockholm University2006
49. L.R. Snyder, JJ Kirk. Sample preparation; Practical HPLC method development, 2nd edition, John Wiley and Sons Inc.; 2000:110-141
50. method of chemical analysis 5th edition Himalaya publication. G. R. Chatwal,s.k.Anand.Instrumentalhttp:/en.wikipedia.org/wiki/ pharmacokinetic studies [collected2011.12.1]
51. XiaobinGonga†, Le Yanga†, Feng Zhanga, YoutianLianga, ShouhongGaoa, KeLiub*, Wansheng Chen, Validated UHPLC-MS/MS assay for the quantitative determination of etoposide, gemcitabine, vinorelbine and their metabolites in lung cancer patients
52. Tashinga E. Bapiro • Frances M. Richards • Mae A. Goldgraben • Kenneth P. Olive • Bassetti Madhu • Kristopher K. Frese • Natalie Cook • Michael A. Jacobetz • Donna-Michelle Smith • David
53. A. Tuveson • John R. GriYths • Duncan I. Jodrell A novel method for quantification of gemcitabine and its metabolites 2,2-diXuorodeoxyuridine and gemcitabine triphosphate in tumor tissue by LC-MS/MS: comparison with 19F NMR Cancer ChemotherPharmacol (2011) 68:1243–1253 DOI 10.1007/s00280-011-1613-0spectroscopy
54. Ling-Zhi Wang,1,2 Wei-Peng Yong,1 Ross-A. Soo,1 Soo-Chin Lee1, Richie Soong2, HowSung Lee,3 Boon-Cher Goh, Rapid Determination of Gemcitabine and Its Metabolite in Human Plasma by LC-MSMS through Micro Protein Precipitation with Minimum Matrix Effect Ling-Zhi Wang et al /J. Pharm. Sci. & Res. Vol.1(3), 2009, 23-32ISSN:0975-1459
55. DP, S. K., P. C, and S. R. Jvln. “development and validation of a dried blood spot lc-ms/ms assay to quantify gemcitabine in human whole blood: a comparison with and without cytidine deaminase inhibitor”. InternationalJournal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 8, Aug. 2015, pp. 75-81,
56. S. A. Veltkamp,1,2∗ M. J. X. Hillebrand,3 H. Rosing,3 R. S. Jansen,3 E. R. Wickremsinhe,5 E. J. Perkins,5 J. H. M. Schellens1,2,4 and J. H. Beijnen2,3,4Quantitative analysis of Gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry journal OF MASS SPECTROMETRY J. Mass Spectrom. 2006; 41: 1633–1642 Published online 20 November 2006 in Wiley InterScience (www.interscience.wiley.com) DOI: 10.1002/jms.1133
57. Michael T. Furlong,∗, Shruti Agrawal b, Dara Hawthornea, Michael Lagoc, Steve Unger d, Linda Krueger d, Bruce Stouffer A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: Application to a clinical pharmacokinetic study journal of Pharmaceutical and Biomedical Analysis 58 (2012) 130–135
58. Hadir M. Maher1,2*, Nourah Z. Alzoman1, Shereen M. Shehata1, Norah O. Abanmy Validated UPLC-MS/MS method for the quantification of dasatinib in plasma: Application to pharmacokinetic interaction studies with nutraceuticals in Wistar rats PLoS ONE | https://doi.org/10.1371/journal.pone.0199208 June 14, 2014
59. Prinesh N. Patel, a GananadhamuSamanthula,*a VeeraraghavanSridhar,bRambabuArla,bKanthi Kiran V. S. Varanasib and Swaroop Kumar V.V.SbValidated LC-MS/MS method for simultaneous determination of Dasatinib and Sitagliptin in rat plasma and its application to pharmacokinetic study This journal is © The Royal Society of Chemistry 2014 Anal. Methods, 2014, 6, 433–439
60. S. R. S. Thappali 1, K. V. S. Varanasi 1, S. Veeraraghavan 1, S. K. V. S. Vakkalanka 1, M. Khagga 2Simultaneous Determination of Methotrexate, Dasatinib, and its Active Metabolite N- Deshydroxyethyl Dasatinib in Rat Plasma by LC-MS/ MS: Method Validation and Application to Pharmacokinetic Study, Thappali SRS et al. Simultaneous determination of methotrexate… Arzneimittelforschung 2012; 62:624–630
61. Wen1, q. Zhang2, y. He1, m. Deng1, x. Wang1, and j. Ma3,* gradient elution lc-ms determination of Dasatinib in Rat Plasma and Its Pharmacokinetic Study 0231–2522 © 2013 AkadémiaiKiadó, Budapes
62. Dai G, Pfister M, Blackwood-Chirchir A, Roy A. Importance of characterizing determinants of variability in exposure: application to dasatinib in subjects with chronic myeloid leukemia. J ClinPharmacol 2008;48:1254e69
63. De Francia S, D'Avolio A, De Martino F, Pirro E, Baietto L, Siccardi M, et al. New HPLCeMS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma. J Chromatogr B Anal Technol Biomed Life Sci 2009;877:1721e6.
64. Haouala A, Zanolari B, Rochat B, Montemurro M, Zaman K, Duchosal MA, et al. Therapeutic drug monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib, and lapatinib by LC tandem mass spectrometry. J Chromatogr B Anal TechnolBiomed Life Sci 2009;877:1982e96
65. Bouchet S, Chauzit E, Ducint D, Castaing N, Canal-Raffin M, Moore N, et al. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra-performance LC/MSeMS. ClinChimActa2011;412:1060e7
66. Boini, K.M., singh, A. and Koka, S.S., 2021. Gut Microbial Metabolite Trimethylamine N-oxide Enhances Endoplasmic Reticular Stress and Promotes Endothelial Dysfunction. Circulation, 144(Suppl_1), pp.A14071-A14071.
67. Sridhar Veeraraghavana,c,∗, SatheeshmanikandanThappali a, SrikantViswanadhaa, SandhyaraniChennupati a, SanthoshkumarNallaa, ManikantakumarGollaa, SwaroopkumarVakkalankaa, ManivannanRangasamySimultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC-MS/MS: Application to a pharmacokinetic study journal of Pharmaceutical and Biomedical Analysis 94 (2014) 125–131
68. clairePressiat, PharmD, PhD,*† Huu-Hien Huynh, PharmD,* Alain Plé,*† Hélène Sauvageon, PharmD,*† Isabelle Madelaine, PharmD, PhD,† Cécile Chougnet, MD,‡ Christine Le Maignan, MD,§ SamiaMourah, PharmD, PhD,*¶ and LaurianeGoldwirt, PharmD, PhDDevelopment and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem MassSpectrometry
69. Vander HY, Nij huis A, Verbeke JS, Vandeginste BG, Massart DL. Guidance for robustness/ruggedness test in method validation. J Pharm Biomed Anal2009;24:723-53.
70. Kringle RO. An assessment of the 4-6-20 rule of acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetic studies. Pharm Res1994;11(4):556-60.
71. Wieling J, Hendriks G, Tamminga WJ, Hempenius J, Mensink CK, Oosterhuis B, et al. Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma. J Chromatogr A1996;730(1-2):381-94.
72. Kringle R, Hoffman D. Stability methods for assessing the stability of compounds in whole blood for clinical bioanalysis. Drug Inf J2001;35:1261-
73. Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, et al. Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays. AAPS J 2007;9(2):E260-7
74. Mark H. Application of improved procedure for testing linearity of an analytical method to pharmaceutical analysis. J Pharm Biomed Anal2003;33(1):7-20
75. Puluido A, Ruusanches I, Boque R, Rius FX. Uncertainty of results in routine qualitative analysis in analytical chemistry. J Pharm Biomed Anal2005;22:647-54
76. Singh PS, Shah G. Analytical method development and validation. J Pharm Res2011;4(5):2330-2
77. Singh UK, Pandey S, Pandey P, Keshri PK, et al. (2008) Bioanalytical method development and validation. ExpressPharma.
78. Murugan S, Pravallika N, Sirisha P, Chandrakala K (2013) A Review on Bioanalytical Method Development and Validation by Using LC-MS/MS. J of Chem and Pharma Sci 6:41-45.
79. McPolin O (2009) Validation of an analytical method for the pharmaceutical analysis, Mourne trainingservices
80. Sekar V, Jayaseelan S, Subash N, Kumar EU, Perumal P, et al. (2009) Bioanalytical Method Development and Validation of Letrozole by Rp-HPLC Method. Int J of Pharm Res and Develop 1: 1- 8.
81. Vinod P. Shah, Bioanalytical Method Validation, A Revisit with a Decade of Progress, Pharmaceutical Research, December 2000, Volume 17, Issue 12, pp 1551–155722.
82. David Watson G., Pharmaceutical Analysis (3 rd Ed., Churchill Livingstone, London: Harcourt Publishers Limited, Essex CM 20 2JE,2012
83. Current Good Manufacturing Practices for Finished Pharmaceuticals, 21 CFR, Parts 210 and 211, US Food and DrugAdministration.
84. Willard HH, Merritt Jr LL, Dean JA, Settle Jr FA. Instrumental methods of analysis.CBS Publ.; 1981:19-90
85. McDowall RD. The role of laboratory information management systems LIMS in analytical method validation. Anal ChimActa 2007; 54:149-5.
86. Wieling J, Hendriks G, Tamminga WJ, Hempenius J, Mensink CK, Oosterhuis B, et al. Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma. J Chromatogr A 1996;730(12):381-9
87. Bmscheck T, Meyer H, Wellhrner HH. A High-performance liquid chromatographic assay for the measurement of azathioprine in human serum samples. J Chromatogr1996;212:287-94.
88. Kees F, Jehnich D, Grobecker H. Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by high-performance liquid chromatography. J Chromatogram1996;677:172-7.
89. Raymond NX, Fan LR, Matt hew J, Tawakol A. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J Pharm Biomed Anal2007;44:342-55.
90. Lau Y, Hanson GD, Carel BJ. Determination of rifampin in human plasma by HPLC with ultraviolet detection. J Chromatogr1998;676:147-52
91. Hartmann C, Massart D, McDowall RD. An analysis of the Washington Conference Report on bioanalytical method validation. J Pharm Biomed Anal 2005;12:1337-43.
92. Karnes HT, Shiu G, Shah VP. Validation of bioanalytical methods. Pharm Res 2001;8:421-6.
93. Lindner W, Wainer IW. Requirements for initial assay validation and publication in J ChromatographyB. J Chromatogr2006;707:1-2.
94. Penninckx W, Hartmann C, Massart DL, Smeyers-Verbeke J. Validation of the Calibration Procedure in Atomic Absorption Spectrometric Methods. J Anal At Spectrom1998;11:237-46.
95. Wieling J, Hendriks G, Tamminga WJ, Hempenius J, Mensink CK, Oosterhuis B, et al. Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma. J Chromatogr2006;730:381-94
96. Dighe S, Shah VP, Midha KK, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. Conference Report. Eur J Drug
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.